A review of antifungal agents.
A vigorous approach to the management of fungal related diseases has been precipitated by a number of issues; HIV/AIDS being one of the most prominent. In line with this there have been a number of new developments that all practitioners should know about. This article reviews the appropriate use of all agents currently available for antifungal treatments. The second part of this article (appearing in the June issue) will look at the clinical applications of these treatment options.
Speed
B
B
Infectious Disease, Fairfield Hospital.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D015497:HIV-1; D006801:Humans; D009181:Mycoses / Q000188:drug therapy
D000935:Antifungal Agents